Using Health Economics To Strengthen Ties Between Evidence, Policy And Practice In Chronic Disease
Funder
National Health and Medical Research Council
Funding Amount
$1,925,648.00
Summary
There is a major shortage of researchers with health economics expertise in Australia. This grant will provide training and development for a team of health economists to research chronic diseases covering issues such as: What is the value for money from investment in different treatments? How do such diseases affect the economic circumstances of families? How do we ensure that strategies to address illness work in practice and can be sustained? How do these issues get put on the policy agenda?
Improving Patient Access To Novel Cancer Drugs In Australia: Striking The Balance
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Cancer patients in Australia may experience delays before they can benefit from new expensive drugs because of the lengthy existing processes to evaluate new medicines by the Department of Health. I will study how to improve the existing drug evaluation processes to make timely but informed funding decisions. This work will improve patient outcomes from early access to effective new cancer drugs and help the government make a wiser spending of public funds.
Building Capacity In Innovative Approaches To Health Technology Assessment
Funder
National Health and Medical Research Council
Funding Amount
$1,552,136.00
Summary
This research will develop innovative approaches to health technology assessment by using a range of data sources analysed using sophisticated econometrics techniques. It will build capacity in new methods of economic evaluation and in econometric analysis of administrative and clinical trial data, using sophisticated approaches to combining data sources. This will allow fuller assessment of cost-effectiveness, incorporating a wide range of possible coverage scenarios and detailed monitoring.
Cardiovascular Disease(CD) affected 3.67 million Australians in 2001. In 2002, it accounted for 37.6% of deaths. Nationally, development and implementation of strategies ensuring up-to-date, multi-disciplinary, cost-effective, and sustainable care for all Australians is needed. This project aims to explore current and future models of management of CD with a particular focus on drug use and health economics. It is hoped that this project will inform the development of improved health policy.
STEP: Improving The Evaluation And Use Of Tests For Screening, Diagnosis And Monitoring In Healthcare.
Funder
National Health and Medical Research Council
Funding Amount
$9,566,865.00
Summary
Medical tests - for screening, diagnosis, and monitoring - are often poorly evaluated and poorly used. This program, run by an established team with skills in public health, clinical epidemiology, biostatistics, health economics and behavioural science, addresses the under-researched issues of whether, when and how to use medical tests. The elements of the program follow the sequence in which testing is often done: for screening (early detection), for diagnosis on which to base treatment decisio ....Medical tests - for screening, diagnosis, and monitoring - are often poorly evaluated and poorly used. This program, run by an established team with skills in public health, clinical epidemiology, biostatistics, health economics and behavioural science, addresses the under-researched issues of whether, when and how to use medical tests. The elements of the program follow the sequence in which testing is often done: for screening (early detection), for diagnosis on which to base treatment decisions, and for monitoring the effects of treatment. A common approach throughout is the identification of the benefits and harms of testing and assessing their trade-offs; how benefits weigh up against harms. This research is relevant to all partners in healthcare - consumers, clinicians and policymakers - who currently are being tested or implementing tests without being fully informed about the accuracy and effects of these tests.Read moreRead less
This project will investigate how policies to fund certain health interventions, effect the utilisation, quality and efficiency of the wider health system. This fellow will work with one of the world’s most comprehensive population level databases to: (1) assess how health systems react to different funding policies; (2) develop a measurement framework to capture the diverse effects of these policies on complex systems; and (3) evaluate how this approach improves the ‘health’ of health systems.
Obesity, Overweight And Hospitalisation: Identifying Targets For Interventions To Prevent Adverse Health Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$603,755.00
Summary
Obesity is an important and rapidly increasing health problem, especially in indigenous communities. The proposed project investigates how obesity affects the risk of hospital admission in Indigenous and non-Indigenous Australians, including providing evidence regarding the nature of the hospitalisation, the cost and whether specific groups are at a higher risk of obesity-related hospitalisation. In doing so it aims to identify targets for intervention to reduce obesity-related hospitalisation
Health insurance design: choices, consumer behavior and policy challenges . Rising health costs is a global challenge. Creating an efficient health insurance system is a key policy concern in all developed countries. This project aims to study choices, consumer behaviors, and policy challenges in two health insurance markets: Australian private health insurance (PHI) and US Medicare prescription drug insurance.
Expected outcomes include new evidence needed to develop a new framework for PHI, ne ....Health insurance design: choices, consumer behavior and policy challenges . Rising health costs is a global challenge. Creating an efficient health insurance system is a key policy concern in all developed countries. This project aims to study choices, consumer behaviors, and policy challenges in two health insurance markets: Australian private health insurance (PHI) and US Medicare prescription drug insurance.
Expected outcomes include new evidence needed to develop a new framework for PHI, new knowledge on how consumers respond to complex pricing structures, and new policy proposals to improve the overall efficiency of the health system. The research will benefit the re-design of PHI and the health system to improve Australians’ health while saving health costs.
Read moreRead less
Understanding Stroke Care Health Service Utilisation Beyond The Acute Hospital Setting
Funder
National Health and Medical Research Council
Funding Amount
$316,449.00
Summary
This project will link data from the Australian Stroke Clinical Registry, the stroke survivor and carer needs survey and Commonwealth and state datasets to obtain a better understanding of the post-discharge health service utilisation of survivors of stroke and how this relates to reported long-term unmet needs in this group. This information will be used to inform interventions to improve outcomes and service delivery for survivors of stroke.